期刊文献+

过氧化物酶体增殖因子活化受体-γ基因多态性与非酒精性脂肪性肝病及脂联素的关系 被引量:5

原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)是遗传-环境-代谢应激相关性疾病。胰岛素抵抗(insulin resistance,IR)是肥胖、2型糖尿病、代谢综合征和NAFLD的共同重要致病机制,脂肪细胞因子如脂联素、瘦素和抵抗素等通过不同途径参与IR和NAFLD的发生和发展。过氧化物酶体增殖因子活化受体-γ(PPAR-γ)在能量、脂质等代谢,脂肪组织分化及其脂肪细胞因子基因调控中起重要作用。
出处 《中华消化杂志》 CAS CSCD 北大核心 2008年第2期113-115,共3页 Chinese Journal of Digestion
基金 本课题系广州市卫生机构重点科研基金资助项目(2004Z001)
  • 相关文献

参考文献10

  • 1李瑜元.第十三届世界消化疾病会议纪要[J].中华消化杂志,2005,25(12):754-756. 被引量:3
  • 2Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest, 2006, 116:581-589.
  • 3Mendez-Sanchez N, Chavez-Tapia NC, Medina-Santillan R, et al. The efficacy of adipokines and indices of metabolic syndrome as predictors of severe obesity-related hepatic steatosis. Dig Dis Sci, 2006, 51:1716-1722.
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1510
  • 5He W, Barak Y, Hevener A, et al. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causesinsulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA, 2003, 100:15712-15717.
  • 6Uno K, Katagiri H, Yamada T, et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science, 2006, 312:1656-1659.
  • 7杨辉,李瑜元,聂玉强,江庆澜,洪勇,沙卫红,石胜利.非酒精性脂肪性肝病患者脂联素基因表达的变化[J].中华消化杂志,2006,26(12):837-838. 被引量:3
  • 8Rhee EJ, Oh KW, Lee WY, et al. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome. Arch Med Res, 2006, 37:86-94.
  • 9Orio F Jr, Palomba S, Cascella T, et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab, 2004, 89:5110-5115.
  • 10Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol, 2003, 38:434-440.

二级参考文献24

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2姜玲玲,洪小飞,厉有名.血清脂联素与肥胖和非酒精性脂肪性肝病关系的研究[J].中华消化杂志,2005,25(4):238-239. 被引量:13
  • 3Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 4Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 5Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 6Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 7Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 8Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 9Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 10Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.

共引文献1512

同被引文献91

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部